Startup profile · funding coverage
CoverMyMeds funding, valuation and investors
Medication access and prior-authorization technology connecting providers, pharmacies, payers, and manufacturers.
Keep track of CoverMyMeds
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Not publicly disclosed
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
acquired
acquired · Columbus, OH
Overview
CoverMyMeds automates prior authorization and related medication access workflows. Founded 2008 in Columbus, Ohio. Acquired by McKesson Corporation in April 2017 and operates as a McKesson business unit with Columbus hub office at 910 John St., Columbus, OH 43222 (also historically Cleveland presence). Product focus: helping patients get needed medicines by reducing access friction.
Why CoverMyMeds is interesting
Columbus healthtech proof point acquired by McKesson (2017); still operates a major Columbus hub at 910 John Street.
Product & use cases
Electronic prior authorization and medication access solutions across the pharmacy/medical benefit ecosystem.
- ePA for providers/pharmacies
- Manufacturer patient support
- Payer medication access workflows
Key facts
- Acquired by McKesson (Apr 2017)
- Columbus hub: 910 John Street, Columbus, OH 43222
- Founded 2008 — prior authorization / medication access software
- McKesson lists CoverMyMeds among major OH business hubs
Funding history (newest first)
Acquisition
2017-04- McKesson (lead)
Source: https://www.covermymeds.com/main/support/general/how-do-you-work-with-mckesson/
Competitive landscape
Edge: Category leadership in ePA plus McKesson distribution after acquisition.
-
Surescripts adjacent
E-prescribing network incumbent.
-
CenterX / other ePA vendors direct
Prior auth competitors.
Industries
Market / IPO context
Editorial / static context — not a live quote.
FAQs about CoverMyMeds
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.